Venrock Adviser, LLC 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Venrock Adviser, LLC disclosed 38 US equity positions worth $1.9bn in its Q3 2024 13F filing. The largest position was APGE at 26.1% of the reported book, followed by OCUL and ELVN.
What did Venrock Adviser, LLC own in Q3 2024? Top 38 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | APGE APOGEE THERAPEUTICS INC | Healthcare | 26.1% | $498.9m | 8,493,321 | – | |
| 2 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 5.8% | $111.0m | 12,762,462 | – | |
| 3 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 5.4% | $102.8m | 4,026,331 | – | |
| 4 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 4.6% | $88.3m | 3,882,709 | – | |
| 5 | APLT APPLIED THERAPEUTICS INC | 4.4% | $83.5m | 9,825,000 | – | ||
| 6 | SYRE SPYRE THERAPEUTICS INC | 4.1% | $79.0m | 2,685,448 | – | ||
| 7 | DYN DYNE THERAPEUTICS INC | Healthcare | 4.1% | $78.1m | 2,173,913 | – | |
| 8 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 4.0% | $75.6m | 3,085,620 | – | |
| 9 | 4XC1 KALVISTA PHARMACEUTICALS INC | 3.8% | $72.4m | 6,249,731 | – | ||
| 10 | PHVS PHARVARIS N V | 3.3% | $62.9m | 3,395,606 | – | ||
| 11 | COGT COGENT BIOSCIENCES INC | Healthcare | 3.2% | $61.4m | 5,684,167 | – | |
| 12 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 2.5% | $47.8m | 1,744,373 | – | |
| 13 | FDMT 4D MOLECULAR THERAPEUTICS IN | 2.5% | $47.6m | 4,400,000 | – | ||
| 14 | MERUS N V | 2.4% | $45.4m | 907,963 | – | ||
| 15 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 2.4% | $45.0m | 4,394,527 | – | |
| 16 | ERAS ERASCA INC | Healthcare | 2.3% | $44.3m | 16,216,216 | – | |
| 17 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 2.1% | $40.6m | 706,131 | – | |
| 18 | CATBUSD ASTRIA THERAPEUTICS INC | 2.0% | $38.1m | 3,458,645 | – | ||
| 19 | 430 TERNS PHARMACEUTICALS INC | 1.5% | $28.4m | 3,410,058 | – | ||
| 20 | AQST AQUESTIVE THERAPEUTICS INC | 1.4% | $27.7m | 5,555,555 | – | ||
| 21 | EWTX EDGEWISE THERAPEUTICS INC | 1.4% | $26.7m | 1,000,000 | – | ||
| 22 | ARTV ARTIVA BIOTHERAPEUTICS INC | 1.3% | $24.9m | 1,609,569 | – | ||
| 23 | ENGENE HOLDINGS INC | 1.2% | $23.5m | 3,565,841 | – | ||
| 24 | CGEM CULLINAN THERAPEUTICS INC | Healthcare | 1.2% | $23.1m | 1,379,965 | – | |
| 25 | MERSANA THERAPEUTICS INC | 1.1% | $21.4m | 11,328,000 | – | ||
| 26 | TSHA TAYSHA GENE THERAPIES INC | Healthcare | 0.9% | $18.1m | 9,000,000 | – | |
| 27 | ABVX ABIVAX SA | 0.8% | $15.5m | 1,345,780 | – | ||
| 28 | TRVI TREVI THERAPEUTICS INC | Healthcare | 0.6% | $11.4m | 3,422,656 | – | |
| 29 | ARVN ARVINAS INC | Healthcare | 0.6% | $11.2m | 454,450 | – | |
| 30 | AVU0 ADVERUM BIOTECHNOLOGIES INC | 0.5% | $10.3m | 1,467,048 | – | ||
| 31 | IPSC CENTURY THERAPEUTICS INC | Healthcare | 0.5% | $9.2m | 5,389,259 | – | |
| 32 | ZURA ZURA BIO LTD | Healthcare | 0.4% | $8.2m | 2,023,166 | – | |
| 33 | PERCEPTIVE CAP SOLUTIONS COR | 0.4% | $7.5m | 750,000 | – | ||
| 34 | CABA CABALETTA BIO INC | Healthcare | 0.4% | $7.4m | 1,563,952 | – | |
| 35 | CASIF CASI PHARMACEUTICALS INC | 0.3% | $6.1m | 987,259 | – | ||
| 36 | TNYA TENAYA THERAPEUTICS INC | 0.2% | $3.0m | 1,555,556 | – | ||
| 37 | TIL INSTIL BIO INC | 0.1% | $2.2m | 33,177 | – | ||
| 38 | TENX TENAX THERAPEUTICS INC | 0.0% | $720.8k | 208,333 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.